Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline LlcfiledCriticalGlaxosmithkline Llc
Priority to CR20140051ApriorityCriticalpatent/CR20140051A/en
Publication of CR20140051ApublicationCriticalpatent/CR20140051A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos de tiazol-sulfonamida y de oxazol-sulfonamida, composiciones que los contienen, procesos para la preparación y métodos para su uso como agentes farmacéuticos.Thiazol-sulfonamide and oxazol-sulfonamide compounds, compositions containing them, processes for the preparation and methods for use as pharmaceutical agents.
CR20140051A2014-01-292014-01-29
BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS
CR20140051A
(en)
Compounds derived from fused aryl and heteroaryl lactams, modulators of ezh2; pharmaceutical composition that includes them; use of the compound for the treatment of cancer.
Compounds derived from substituted 1,3,5-triazines and their salts, as inhibitors of mutant idh2; pharmaceutical composition that includes them; and its use for the treatment of cancer.
OPTIONALLY CONDENSED HYDERO-CYCLIC DERIVATIVES OF PIRIDIMINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOINMUNITY DISEASES
Use of substituted aminotriazolopyridine compounds, in the treatment of inflammatory, autoimmune, proliferative, allergy, transplant rejection, among others; pharmaceutical composition that includes them; pharmaceutical combination.